Veterinary medicines European public assessment report (EPAR): Firocoxib CP-Pharma, firocoxib, Status: Opinion

Veterinary medicines European public assessment report (EPAR): Varenzin, molidustat, Status: Opinion

Summary of opinion: Dexdomitor, 04/12/2025 Positive

Veterinary medicines European public assessment report (EPAR): Epizootic haemorrhagic disease vaccine (recombinant protein) Laboratorios Syva S.A., Epizootic haemorrhagic disease vaccine (recombinant protein), Status: Opinion

Human medicines European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene), pomalidomide, Date of authorisation: 05/08/2013, Revision: 26, Status: Authorised

Applications for new human medicines under evaluation: December 2025

Medicines for human use under evaluation

Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use'

All languages - Annex to the European Commission guideline on ‘Excipients in the labelling and package leaflet of medicinal products for human use’ (SANTE-2017-11668) - Revision 5

Opinion/decision on a Paediatric investigation plan (PIP): Cibinqo, abrocitinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: EMA/PE/0000183059